PUBLISHER: Grand View Research | PRODUCT CODE: 1888814
PUBLISHER: Grand View Research | PRODUCT CODE: 1888814
The Middle East & Africa probiotic dietary supplement market size was valued at USD 289.4 million in 2024 and is projected to reach USD 423.3 million by 2030, growing at a CAGR of 6.3% from 2025 to 2030. The growth is driven by rising consumer awareness of digestive and immune health, a shift toward preventive healthcare, and increasing demand for convenient supplement formats.
Probiotics are beneficial live microorganisms, including certain types of bacteria and yeasts, that can improve health when consumed adequately. These advantageous microbes are commonly found in various fermented foods and can also be included in different products or taken as dietary supplements. Their key function area is the digestive tract, where they help maintain a healthy composition of the gut microbiome, a diverse collection of microorganisms primarily located in the large intestine. By helping maintain a balanced gut microbiota, probiotics safeguard the digestive system from harmful entities and enhance digestion and overall gut health.
In addition, they may provide further health advantages beyond digestive wellness, such as improving the immune system, mitigating inflammation, and even positively influencing mental well-being.
Middle East & Africa Probiotic Dietary Supplement Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Middle East & Africa probiotic dietary supplement market report on the basis of form, application, end use, and country: